{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:13:47Z","timestamp":1788545627319,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.mayocp.2017.11.007","type":"journal-article","created":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T06:47:43Z","timestamp":1514875663000},"page":"59-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs Syndrome"],"prefix":"10.1016","volume":"93","author":[{"given":"Michael H.","family":"Silber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Buchfuhrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Earley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Ondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur S.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Winkelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mayocp.2017.11.007_bib1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/mds.23430","article-title":"Prevalence and disease burden of primary restless legs syndrome: results of a general population survey in the United States","volume":"26","author":"Allen","year":"2011","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.mayocp.2017.11.007_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.sleep.2009.03.007","article-title":"Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: prevalence and characteristics","volume":"11","author":"Allen","year":"2010","journal-title":"Sleep Med"},{"issue":"9","key":"10.1016\/j.mayocp.2017.11.007_bib3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.mayocp.2013.06.016","article-title":"Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome","volume":"88","author":"Silber","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"10.1016\/j.mayocp.2017.11.007_bib4","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.sleep.2012.08.004","article-title":"Long-term use of pramipexole in the management of restless legs syndrome","volume":"13","author":"Lipford","year":"2012","journal-title":"Sleep Med"},{"issue":"5","key":"10.1016\/j.mayocp.2017.11.007_bib5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.sleep.2010.11.002","article-title":"A\u00a010-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome","volume":"12","author":"Silver","year":"2011","journal-title":"Sleep Med"},{"issue":"15","key":"10.1016\/j.mayocp.2017.11.007_bib6","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.mayocp.2017.11.007_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jsmc.2015.05.022","article-title":"Restless legs syndrome\/Willis-Ekbom disease pathophysiology","volume":"10","author":"Allen","year":"2015","journal-title":"Sleep Med Clin"},{"key":"10.1016\/j.mayocp.2017.11.007_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.pharmtox.40.1.389","article-title":"Molecular mechanisms and regulation of opioid receptor signaling","volume":"40","author":"Law","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"6549","key":"10.1016\/j.mayocp.2017.11.007_bib9","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/377532a0","article-title":"Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor","volume":"377","author":"Meunier","year":"1995","journal-title":"Nature"},{"issue":"1-2","key":"10.1016\/j.mayocp.2017.11.007_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jns.2008.12.022","article-title":"Does the endogenous opiate system play a role in the restless legs syndrome? A pilot post-mortem study","volume":"279","author":"Walters","year":"2009","journal-title":"J\u00a0Neurol Sci"},{"issue":"4","key":"10.1016\/j.mayocp.2017.11.007_bib11","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.neuroimage.2004.10.021","article-title":"Bilateral thalamic gray matter changes in patients with restless legs syndrome","volume":"24","author":"Etgen","year":"2005","journal-title":"Neuroimage"},{"issue":"12","key":"10.1016\/j.mayocp.2017.11.007_bib12","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/mds.21608","article-title":"Cortical grey matter alterations in idiopathic restless legs syndrome: an optimized voxel-based morphometry study","volume":"22","author":"Unrath","year":"2007","journal-title":"Mov Disord"},{"issue":"Pt 12","key":"10.1016\/j.mayocp.2017.11.007_bib13","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1093\/brain\/aws266","article-title":"Abnormal medial thalamic metabolism in patients with idiopathic restless legs syndrome","volume":"135","author":"Rizzo","year":"2012","journal-title":"Brain"},{"issue":"Pt 4","key":"10.1016\/j.mayocp.2017.11.007_bib14","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/brain\/awh441","article-title":"The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study","volume":"128","author":"Von Spiczak","year":"2005","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.mayocp.2017.11.007_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.903370102","article-title":"The organization of projections from the mediodorsal nucleus of the thalamus to orbital and medial prefrontal cortex in macaque monkeys","volume":"337","author":"Ray","year":"1993","journal-title":"J\u00a0Comp Neurol"},{"issue":"3","key":"10.1016\/j.mayocp.2017.11.007_bib16","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0022-3565(25)24578-5","article-title":"Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats","volume":"244","author":"Di Chiara","year":"1988","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.mayocp.2017.11.007_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/syn.10078","article-title":"Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man","volume":"45","author":"Hagelberg","year":"2002","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.mayocp.2017.11.007_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000116643","article-title":"Restless legs syndrome and periodic leg movements in sleep: the primary role of dopaminergic mechanism","volume":"31","author":"Montplaisir","year":"1991","journal-title":"Eur Neurol"},{"issue":"4","key":"10.1016\/j.mayocp.2017.11.007_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1389-9457(02)00011-4","article-title":"Review of receptor agonist and antagonist studies relevant to the opiate system in restless legs syndrome","volume":"3","author":"Walters","year":"2002","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.mayocp.2017.11.007_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1389-9457(00)00025-3","article-title":"Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients","volume":"2","author":"Winkelmann","year":"2001","journal-title":"Sleep Med"},{"key":"10.1016\/j.mayocp.2017.11.007_bib21","first-page":"309","article-title":"Dominantly inherited restless legs with myoclonus and periodic movements of sleep: a syndrome related to the endogenous opiates?","volume":"43","author":"Walters","year":"1986","journal-title":"Adv Neurol"},{"issue":"10","key":"10.1016\/j.mayocp.2017.11.007_bib22","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1212\/WNL.36.10.1363","article-title":"Dyskinesias while awake and periodic movements in sleep in restless legs syndrome: treatment with opioids","volume":"36","author":"Hening","year":"1986","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.mayocp.2017.11.007_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00002826-198702000-00007","article-title":"Restless legs syndrome treatment with dopaminergic drugs","volume":"10","author":"Akpinar","year":"1987","journal-title":"Clin Neuropharmacol"},{"issue":"12","key":"10.1016\/j.mayocp.2017.11.007_bib24","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1474-4422(13)70239-4","article-title":"Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension","volume":"12","author":"Trenkwalder","year":"2013","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.mayocp.2017.11.007_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1389-9457(02)00258-7","article-title":"Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome","volume":"4","author":"Walters","year":"2003","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.mayocp.2017.11.007_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/sleep\/16.4.327","article-title":"Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo","volume":"16","author":"Walters","year":"1993","journal-title":"Sleep"},{"issue":"6","key":"10.1016\/j.mayocp.2017.11.007_bib27","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/mds.1214","article-title":"Long-term follow-up on restless legs syndrome patients treated with opioids","volume":"16","author":"Walters","year":"2001","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.mayocp.2017.11.007_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/mds.20359","article-title":"Methadone for refractory restless legs syndrome","volume":"20","author":"Ondo","year":"2005","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.mayocp.2017.11.007_bib29","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/jama.283.10.1303","article-title":"Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial","volume":"283","author":"Sees","year":"2000","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mayocp.2017.11.007_bib30","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1074\/jbc.272.2.782","article-title":"Differential opioid agonist regulation of the mouse mu opioid receptor","volume":"272","author":"Blake","year":"1997","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.mayocp.2017.11.007_bib31","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1213\/01.ANE.0000099723.75548.DF","article-title":"Functional inhibition by methadone of N-methyl-D-aspartate receptors expressed in Xenopus oocytes: stereospecific and subunit effects","volume":"98","author":"Callahan","year":"2004","journal-title":"Anesth Analg"},{"issue":"8","key":"10.1016\/j.mayocp.2017.11.007_bib32","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1212\/WNL.54.8.1609","article-title":"Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex","volume":"54","author":"Bara-Jimenez","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.mayocp.2017.11.007_bib33","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/1531-8257(200001)15:1<154::AID-MDS1025>3.0.CO;2-Q","article-title":"Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome","volume":"15","author":"Ondo","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.mayocp.2017.11.007_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sleep.2016.01.017","article-title":"Guidelines for the first-line treatment of restless legs syndrome\/Willis\u2013Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation","volume":"21","author":"Garcia-Borreguero","year":"2016","journal-title":"Sleep Med"},{"key":"10.1016\/j.mayocp.2017.11.007_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.sleep.2016.07.028","article-title":"Iron and restless legs syndrome: treatment, genetics and pathophysiology","volume":"31","author":"Connor","year":"2017","journal-title":"Sleep Med"},{"issue":"9","key":"10.1016\/j.mayocp.2017.11.007_bib36","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.sleep.2010.07.007","article-title":"Restless legs syndrome: understanding its consequences and the need for better treatment","volume":"11","author":"Earley","year":"2010","journal-title":"Sleep Med"},{"issue":"2","key":"10.1016\/j.mayocp.2017.11.007_bib37","first-page":"113","article-title":"Opioid treatment guidelines: clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J\u00a0Pain"},{"issue":"2","key":"10.1016\/j.mayocp.2017.11.007_bib38","first-page":"131","article-title":"Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline","volume":"10","author":"Chou","year":"2009","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.mayocp.2017.11.007_bib39","author":"Brown"},{"issue":"6","key":"10.1016\/j.mayocp.2017.11.007_bib40","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med"},{"issue":"4","key":"10.1016\/j.mayocp.2017.11.007_bib41","first-page":"360","article-title":"Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R)","volume":"9","author":"Butler","year":"2008","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.mayocp.2017.11.007_bib42","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.sleep.2017.05.010","article-title":"Acute and painful exacerbation of RLS and PLM induced by opioid interaction - withdrawal syndrome","volume":"36","author":"Hogl","year":"2017","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.mayocp.2017.11.007_bib43","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4088\/JCP.v60n0407","article-title":"Treatment of restless legs syndrome with tramadol: an open study","volume":"60","author":"Lauerma","year":"1999","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"9","key":"10.1016\/j.mayocp.2017.11.007_bib44","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/17425255.2016.1198320","article-title":"Opioids in the treatment of restless legs syndrome: pharmacological and clinical aspects","volume":"12","author":"De Biase","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"2","key":"10.1016\/j.mayocp.2017.11.007_bib45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-152-2-201001190-00006","article-title":"Overdose and prescribed opioids: associations among chronic non-cancer pain patients","volume":"152","author":"Dunn","year":"2010","journal-title":"Ann Intern Med"},{"issue":"13","key":"10.1016\/j.mayocp.2017.11.007_bib46","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.mayocp.2017.11.007_bib47","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archinternmed.2011.117","article-title":"Opioid dose and drug-related mortality in patients with nonmalignant pain","volume":"171","author":"Gomes","year":"2011","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.mayocp.2017.11.007_bib48","first-page":"321","article-title":"Methadone safety: a clinical practice guideline from the American Pain Society and College on problems of drug dependence, in collaboration with the Heart Rhythm Society","volume":"15","author":"Chou","year":"2014","journal-title":"J\u00a0Pain"},{"issue":"7","key":"10.1016\/j.mayocp.2017.11.007_bib49","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.sleep.2006.05.011","article-title":"Restless legs syndrome augmentation associated with tramadol","volume":"7","author":"Earley","year":"2006","journal-title":"Sleep Med"},{"issue":"3","key":"10.1016\/j.mayocp.2017.11.007_bib50","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mds.21342","article-title":"Augmentation of restless legs syndrome with long-term tramadol treatment","volume":"22","author":"Vertrugno","year":"2007","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.mayocp.2017.11.007_bib51","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.sleep.2015.08.005","article-title":"Opioid-induced hyperalgesia and dopamine-induced augmentation in an intractable and refractory case of RLS","volume":"16","author":"Chokroverty","year":"2015","journal-title":"Sleep Med"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961730825X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961730825X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T05:55:06Z","timestamp":1751176506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002561961730825X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S002561961730825X"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2017.11.007","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs Syndrome","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2017.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}